Valerie M. Lewis

Valerie M. Lewis

Auto-generated profile, based on publicly available information

Valerie M. Lewis

Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma; Oklahoma City US Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2022 in ACR Open Rheumatology
Verified
Journal Article
Open access
RSR Hal Scofield
R Hal Scofield
VLValerie M. Lewis
Valerie M. Lewis
JCJoshua Cavitt
Joshua Cavitt
BKBiji T. Kurien
Biji T. Kurien
SAShervin Assassi
Shervin Assassi
FMFrederick W. Miller
Frederick W. Miller
Objective: We undertook this study to examine the X chromosome complement in participants with systemic sclerosis (SSc) as well as idiopathic inflammatory myopathies.Methods: The participants met classification criteria for the diseases. All participants underwent single‐nucleotide polymorphism typing. We examined X and Y single‐nucleotide polymorphism heterogeneity to determine the number of X chromosomes. For statistical comparisons, we used χ2 analyses with calculation of 95% confidence intervals.Results: Three of seventy men with SSc had 47,XXY (P = 0.0001 compared with control men). Among the 435 women with SSc, none had 47,XXX. Among 709 men with polymyositis or dermatomyositis (PM/DM), seven had 47,XXY (P = 0.0016), whereas among the 1783 women with PM/DM, two had 47,XXX. Of 147 men with inclusion body myositis (IBM), six had 47,XXY, and 1 of the 114 women with IBM had 47,XXX. For each of these myositis disease groups, the excess 47,XXY and/or 47,XXX was significantly higher compared with in controls as well as the known birth rate of Klinefelter syndrome or 47,XXX.Conclusion: Klinefelter syndrome (47,XXY) is associated with SSc and idiopathic inflammatory myopathies, similar to other autoimmune diseases with type 1 interferon pathogenesis, namely, systemic lupus erythematosus and Sjögren syndrome.

3 May 2025 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
MTMartha Tsaliki
Martha Tsaliki
JCJoshua Cavett
Joshua Cavett
BKBiji T Kurien
Biji T Kurien
CBChristina Bruxvoort
Christina Bruxvoort
VLValerie M. Lewis
Valerie M. Lewis
RSR Hal Scofield
R Hal Scofield